Martin Shkreli violated lifetime pharma industry ban, FTC and states say

NEW YORK, Oct 13 (Reuters) – Martin Shkreli has violated a lifetime ban from the pharmaceutical industry by trading stocks and discussing his opinions about companies in the industry, federal and

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)